20/20 Biolabs FY EPS $(0.76) Up From $(1.16) YoY, Sales $2.045M Up From $1.752M YoY

Benzinga Newsdesk www.benzinga.com Negative 82.1%

Neg 82.1% Neu 0% Pos 0%

20/20 Biolabs (NASDAQ:AIDX) reported quarterly losses of $(0.76) per share. This is a 34.48 percent increase over losses of $(1.16) per share from the same period last year. The company reported $2.045 million in sales this quarter. This is a 16.72 percent increase over sales of $1.752 million the same period last year.